发明申请
US20120264200A1 SYSTEMS AND METHODS FOR ISOLATING AND USING CLINICALLY SAFE ADIPOSE DERIVED REGENERATIVE CELLS
有权
用于分离和使用临床安全性ADIPOSE衍生的再生细胞的系统和方法
- 专利标题： SYSTEMS AND METHODS FOR ISOLATING AND USING CLINICALLY SAFE ADIPOSE DERIVED REGENERATIVE CELLS
- 专利标题（中）： 用于分离和使用临床安全性ADIPOSE衍生的再生细胞的系统和方法
-
申请号： US13452349申请日： 2012-04-20
-
公开(公告)号： US20120264200A1公开(公告)日： 2012-10-18
- 发明人: Marc H. Hedrick , John K. Fraser , Michael J. Schulzki , Bobby Byrnes , Grace Carlson , Rhonda Elizabeth Schreiber , Isabella Wulur
- 申请人： Marc H. Hedrick , John K. Fraser , Michael J. Schulzki , Bobby Byrnes , Grace Carlson , Rhonda Elizabeth Schreiber , Isabella Wulur
- 申请人地址： US CA SAN DIEGO
- 专利权人： CYTORI THERAPEUTICS, INC.
- 当前专利权人： CYTORI THERAPEUTICS, INC.
- 当前专利权人地址： US CA SAN DIEGO
- 主分类号： C12M1/12
- IPC分类号： C12M1/12
摘要：
Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g., stem and/or progenitor cells, from adipose tissue. The systems and methods described herein provide rapid and reliable methods of separating and concentrating regenerative cells suitable for re-infusion into a subject.
公开/授权文献
信息查询
